Related Articles
Prognostic factors of long‑term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12‑year experience from a single center
Tumour stem cell markers CD133 and CD44 are useful prognostic factors after surgical resection of pancreatic neuroendocrine tumours
AMIGO2 expression as a predictor of recurrence in cervical cancer with intermediate risk
Immunohistochemical analyses of the expression profiles of INSM1, ATRX, DAXX and DLL3 in solid papillary carcinomas of the breast
Surgery management for sporadic small (≤2 cm), non-functioning pancreatic neuroendocrine tumors: a consensus statement by the Chinese Study Group for Neuroendocrine Tumors (CSNET)